It remains unclear if there’s a connection between the two.
of e-cigarette users experiencing seizures, and hasn’t detected a pattern among the reports, as scientists have yet to fully determine the long-term health impact of vaping.
The FDA announced in April that it was investigating 32 reports of people suffering seizures after vaping. Since then, 92 more reports were made to the agency. The cases occurred from 2009 to 2019 among youth users and adults, and the FDA said it’s unclear if e-cigarettes caused the seizures.In addition, the FDA said in some of the cases, users had pre-existing seizure diagnoses, or used additional drugs, like marijuana, along with the e-cigarettes., as well as dizziness, nausea, tremors, or even death.—and that e-cigarettes are a less dangerous nicotine source than tobacco cigarettes, but recommends that nonsmokers stay away from vaping.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Investigates 127 Seizure Reports Potentially Linked To VapingIt remains unclear if there’s a connection between the two.
Read more »
FDA investigating 127 reports of seizures after vapingThe FDA cautions it's unclear whether e-cigarettes caused the seizures.
Read more »
FDA investigating 127 reports of vaping-related seizures, neurological symptomsThe US Food and Drug Administration has received 127 reports of seizures or other neurological symptoms possibly related to e-cigarettes, the agency announced Wednesday. Investigators have yet to determine, however, whether vaping was directly linked to the cases.
Read more »
FDA investigating 127 reports of seizures, other neurological symptoms after vapingFDA investigating 127 reports of people suffering seizures or other neurological symptoms after using e-cigarettes, agency announces.
Read more »
Company knew about manipulated data before FDA approved $2 million gene therapy, agency saysThe maker of Zolgensma, a gene therapy for babies, did not inform federal regulators about 'data manipulation that created inaccuracies' until after its $2.1 million treatment was approved, the US Food and Drug Administration said Tuesday.
Read more »
FDA raises accuracy questions over trial data of $2 million gene therapy drugMore than 2 months after the FDA approved an expensive new gene therapy drug for a rare disease in children, the agency said it has major questions about the accuracy of some of the testing data.
Read more »